Zavedos (idarubicin hydrochloride) lyophilisate for infusions 5 mg. vial №1


Manufacturer: Italy



For the treatment of acute myeloid leukemia in adults, for the induction of remission in previously untreated patients, or in patients with relapsed or refractory disease. As a second-line drug for the treatment of relapses of acute lymphoblastic leukemia in adults and children.